| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Shawver Laura is a Director at ARS Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2023 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 100,000 | $6.84 | $684,041.15 | -19.2% | -2.1% | +22.7% | |
| May 9, 2023 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 143,896 | $5.42 | $780,578.68 | -18.6% | +34.1% | +75.9% |